Lipid nanoparticle encapsulated TLR3 agonist adjuvant elicits potent T cell immunity against cancer and viruses.
Saved in:
| Title: | Lipid nanoparticle encapsulated TLR3 agonist adjuvant elicits potent T cell immunity against cancer and viruses. |
|---|---|
| Authors: | Ko KH; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Lee SH; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Choi YH; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Kang SM; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Yang HS; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Lee SM; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Jo EB; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Bae HS; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Hong SB; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Kim DH; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea. dhk@navaccine.org., Cha SB; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea. sbcha@navaccine.org. |
| Source: | NPJ vaccines [NPJ Vaccines] 2025 Dec 23; Vol. 11 (1), pp. 26. Date of Electronic Publication: 2025 Dec 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41436456 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Lipid nanoparticle encapsulated TLR3 agonist adjuvant elicits potent T cell immunity against cancer and viruses. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ko+KH%22">Ko KH</searchLink>; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SH%22">Lee SH</searchLink>; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Choi+YH%22">Choi YH</searchLink>; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kang+SM%22">Kang SM</searchLink>; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yang+HS%22">Yang HS</searchLink>; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SM%22">Lee SM</searchLink>; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jo+EB%22">Jo EB</searchLink>; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Bae+HS%22">Bae HS</searchLink>; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Hong+SB%22">Hong SB</searchLink>; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+DH%22">Kim DH</searchLink>; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea. dhk@navaccine.org.<br /><searchLink fieldCode="AU" term="%22Cha+SB%22">Cha SB</searchLink>; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea. sbcha@navaccine.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101699863%22">NPJ vaccines</searchLink> [NPJ Vaccines] 2025 Dec 23; Vol. 11 (1), pp. 26. <i>Date of Electronic Publication: </i>2025 Dec 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature+in+partnership+with+the+Sealy+Center+for+Vaccine+Development%22">Springer Nature in partnership with the Sealy Center for Vaccine Development </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101699863 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-0105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220590105%22">20590105 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Vaccines <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41436456 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41541-025-01349-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 26 Titles: – TitleFull: Lipid nanoparticle encapsulated TLR3 agonist adjuvant elicits potent T cell immunity against cancer and viruses. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ko KH – PersonEntity: Name: NameFull: Lee SH – PersonEntity: Name: NameFull: Choi YH – PersonEntity: Name: NameFull: Kang SM – PersonEntity: Name: NameFull: Yang HS – PersonEntity: Name: NameFull: Lee SM – PersonEntity: Name: NameFull: Jo EB – PersonEntity: Name: NameFull: Bae HS – PersonEntity: Name: NameFull: Hong SB – PersonEntity: Name: NameFull: Kim DH – PersonEntity: Name: NameFull: Cha SB IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 12 Text: 2025 Dec 23 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2059-0105 Numbering: – Type: volume Value: 11 – Type: issue Value: 1 Titles: – TitleFull: NPJ vaccines Type: main |
| ResultId | 1 |